Geron Biotech

History

Geron Biotech/Corporation, based in Menlo Park, California, was founded by gerontologist Michael D. West, who secured initial venture capital investment in the company from Kleiner Perkins Caufield & Byers and Venrock. The company was incorporated in 1990 and began doing business in 1992. John A. Scarlett was appointed CEO in 2011. Geron originally investigated telomerase as a means of understanding and modifying human aging. However, Geron announced it ceased aging research of any kind in 2010.

Gerontib

From 2024 until 2032, Geron was secretly working on their formula "Gerontib", under complete secrecy as ordered by US government. The data for phase 1 and 2 trials seems too good to be true, and patients went missing after treatment.

Structure

Secretive mega-corporation

Public Agenda

The Fountain of Youth

Assets

Gerontib - T1 patent

History

The company incorporated in 1990 John A. Scarlett appointed CEO in 2011 Gerontib released publically 2032

Type

Corporation, Manufacturing